Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about REGN

Recent news which mentions REGN

< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
Here's How Much $100 Invested In Regeneron Pharmaceuticals 15 Years Ago Would Be Worth Today
Tickers NEWS REGN
Tags Benzinga Trading Ideas Market News
From Benzinga
What the Options Market Tells Us About Regeneron Pharmaceuticals
Tickers REGN
Tags Market News Markets BZI/UOA
From Benzinga
Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
Tickers AMGN AZN BMRN GILD
Tags AMGN Top Stories Stories That Matter
From Benzinga
Inquiry Into Regeneron Pharmaceuticals's Competitor Dynamics In Biotechnology Industry
Tickers NEWS REGN
Tags News REGN Market News
From Benzinga
Regeneron Chief Flags Health Risks with Popular Weight-Loss Medications Like Ozempic, Says Company Targets Muscle Preservation For Its Obesity Drugs
Tickers LLY NEWS NVO REGN
Tags General News Briefs
From Benzinga
Should You Buy the Dip on This Top Growth Stock?
Tickers AMGN REGN
Tags REGN Recent Press Releases AMGN
From Motley Fool
A Closer Look at 24 Analyst Recommendations For Regeneron Pharmaceuticals
Tickers REGN
Tags Analyst Ratings Market News BZI/AAR
From Benzinga
Market Whales and Their Recent Bets on REGN Options
Tickers REGN
Tags Market News Markets BZI/UOA
From Benzinga
(REGN) - Analyzing Regeneron Pharmaceuticals's Short Interest
Tickers REGN
Tags Short Sellers REGN Market News
From Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $400 Today
Tickers NEWS REGN
Tags News REGN BZI/POD
From Benzinga
Regeneron Pharma, Super Micro Computer And Global Payments Are Among Top 10 Large Cap Losers Last Week (Sept 23-Sept 27): Are The Others In Your Portfolio?
Tickers AFRM FCNCA FTI GPN
Tags Large Cap FTI REGN
From Benzinga
FDA Approves Regeneron/Sanofi's Blockbuster Dupixent For Smoker's Lung Disease
Tickers NEWS REGN SNY
Tags General Movers why it's moving
From Benzinga
Taiwan Semiconductor, American Tower, Trane Technologies And A Health Care Stock On CNBC's 'Final Trades'
Tickers AMGN AMT NEWS REGN
Tags REGN Stephen Weiss TSM
From Benzinga
A Closer Look at Regeneron Pharmaceuticals's Options Market Dynamics
Tickers REGN
Tags REGN Options Benzinga
From Benzinga
Exploring The Competitive Space: Regeneron Pharmaceuticals Versus Industry Peers In Biotechnology
Tickers NEWS REGN
Tags News REGN Market News
From Benzinga
Amgen's Rocatinlimab Data Beats Placebo In Atopic Dermatitis Trial, But Analyst Says Data Raises Concerns Amid Competitive Market
Tickers AMGN CGEM NEWS REGN
Tags Health Care REGN Large Cap
From Benzinga
Why Is Regeneron Pharmaceuticals Stock Trading Lower On Tuesday?
Tickers AMGN NEWS REGN VTRS
Tags AMGN VTRS General
From Benzinga
This BP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Tickers BIDU BP FHN MCK
Tags Markets MCK Analyst Ratings
From Benzinga
Smart Money Is Betting Big In REGN Options
Tickers REGN
Tags Market News BZI/UOA Markets
From Benzinga
Competitor Analysis: Evaluating Regeneron Pharmaceuticals And Competitors In Biotechnology Industry
Tickers NEWS REGN
Tags News REGN Markets
From Benzinga
Sanofi, Regeneron Drug Dupixent Shows Successful Treatment Of Patients With Inflammatory Skin Disease
Tickers NEWS REGN SNY
Tags Briefs SNY News
From Benzinga
Prediction: These 2 Companies Will Split Their Stocks by 2027
Tickers LLY REGN
Tags Recent Press Releases LLY REGN
From Motley Fool
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,000 Today
Tickers NEWS REGN
Tags News BZI/POD REGN
From Benzinga
Beyond The Numbers: 20 Analysts Discuss Regeneron Pharmaceuticals Stock
Tickers REGN
Tags Benzinga BZI/AAR REGN
From Benzinga
Prediction: These 2 Cathie Wood Stocks Could Crush the Market Through 2030
Tickers REGN SHOP
Tags Market News SHOP Recent Press Releases
From Motley Fool
Evaluating Regeneron Pharmaceuticals Against Peers In Biotechnology Industry
Tickers NEWS REGN
Tags Markets Market News BZI/IA
From Benzinga
What Analysts Are Saying About Regeneron Pharmaceuticals Stock
Tickers REGN
Tags BZI/AAR REGN Benzinga
From Benzinga
Regeneron Faces Setback With FDA Rejection Of Blood-Cancer Treatment
Tickers NEWS REGN
Tags Benzinga FDA Markets
From Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $130 Thousand Today
Tickers NEWS REGN
Tags Market News Benzinga Trading Ideas
From Benzinga
7 Stocks That Usually Benefit From a Recession
Tickers BUD CTAS MCD REGN
Tags REGN CTAS MCD
From InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.